AMAG Pharmaceuticals Inc (AMAG.O)

AMAG.O on Nasdaq

18 Dec 2014
Price Change (% chg)

$2.81 (+6.94%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for AMAG.O


AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company markets Feraheme, an iron compound for the treatment of iron deficiency anemia in adult patients, and MuGard Mucoadhesive Oral Wound Rinse, an oral rinse for treating oral mucositis. Feraheme (ferumoxytol) Injection is indicated for the treatment of... (more)


Beta: 0.02
Market Cap (Mil.): $894.62
Shares Outstanding (Mil.): 22.09
Dividend: --
Yield (%): --


  AMAG.O Industry Sector
P/E (TTM): -- 36.60 37.24
EPS (TTM): -0.50 -- --
ROI: -3.36 18.95 18.21
ROE: -5.84 19.73 19.11
Search Stocks

Amag Pharma enters women health business with $675 million deal

- Amag Pharmaceuticals Inc entered the women's healthcare business by acquiring privately held Lumara Health Inc for $675 million in its biggest deal ever, sending its shares up as much as 23 percent to a four-year high.

29 Sep 2014

UPDATE 2-Amag Pharma enters women health business with $675 mln deal

(Adds CEO and analyst comments, background, updates stock price)

29 Sep 2014

BUZZ-U.S. Stocks on the Move-Ambit, Athlon, Tonix, Tibco, Amag

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter,; for the Morning News Call newsletter,

29 Sep 2014

Deals of the day- Mergers and acquisitions

(Adds Encana Corp, Nestle, Tibco Software, Amag Pharmaceuticals; Updates Strides Arcolab and Barco)

29 Sep 2014

Amag Pharma buys women's health company Lumara for $675 mln

Sept 29 - Amag Pharmaceuticals Inc said it would buy privately held women's healthcare company Lumara Health Inc for $675 million in cash and stock, gaining access to the only approved product designed to reduce the risk of preterm birth.

29 Sep 2014


Earnings vs. Estimates

Search Stocks